Structure Therapeutics Inc.
GPCR
$56.65
$2.905.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.24% | -90.58% | -78.17% | -46.73% | -36.72% |
| Total Depreciation and Amortization | 68.47% | 47.74% | 76.84% | 123.93% | 215.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 178.03% | 517.53% | 205.67% | 552.48% | -32.28% |
| Change in Net Operating Assets | -3,070.34% | -15.45% | 299.73% | 24.88% | -57.45% |
| Cash from Operations | -90.51% | -90.63% | -58.57% | -44.53% | -46.73% |
| Capital Expenditure | -180.16% | 12.18% | 51.38% | 38.09% | 40.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 123.25% | 111.20% | 79.61% | -50.69% | -34.35% |
| Cash from Investing | 125.02% | 111.68% | 79.41% | -49.74% | -33.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 47.98% | -92.71% | -99.69% | 71.55% | 9.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.47% | 96.20% | 93.97% | 90.83% | 91.67% |
| Cash from Financing | 47.99% | -92.70% | -99.85% | 82.43% | 14.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,486.47% | -156.97% | -168.79% | 289.42% | -61.70% |